Ashley N. Mays-WilliamsAshley N.Mays-Williams
Partner, Intellectual Property
Ashley Mays-Williams, Ph.D. is a partner in the Litigation Department of Paul Hastings and is based in the firm’s New York office. Her practice primarily focuses on intellectual property law, particularly patent litigation matters in the fields of pharmaceuticals and biotechnology.
Ashley has experience litigating cases arising under the Hatch-Waxman Act on behalf of innovator companies. She has represented life science companies in litigations involving pharmaceutical compounds, pharmaceutical formulations and antibody technology. Ashley has also represented and counseled clients in numerous other technology areas including medical devices, bone pastes and cements, and batteries.
Ashley received her J.D. from William Mitchell College of Law, cum laude, in 2012 where she served as a member of the intellectual property law review journal Cybaris®.
Daiichi Sankyo in a hotly contested, multi-billion-dollar breach of contract intellectual property biotechnology dispute involving antibody-drug conjugates (“ADCs”) for the treatment of various cancers.
Eisai Inc. in a patent infringement case involving Targretin® (bexarotene), an oral treatment for cutaneous T-cell lymphoma.